Women's Guide to Research Compounds

This guide covers the unique considerations for women using research compounds — from hormonal interactions and contraindications to dosing adjustments and protocols tailored for female physiology.

Disclaimer: This guide is for educational and research purposes only. It is not medical advice. Always consult a qualified healthcare provider before beginning any research protocol, especially if you are pregnant, breastfeeding, or have hormonal conditions.

Why Women Need a Separate Guide

Most research compound dosing data comes from studies conducted primarily on male subjects. Female physiology differs in critical ways:

• Hormonal fluctuations — Estrogen, progesterone, and other hormones shift throughout the menstrual cycle, affecting compound absorption, metabolism, and efficacy.
• Body composition — Women typically have higher body fat percentages and lower lean mass, which influences dosing calculations for weight-based protocols.
• Enzyme activity — Differences in liver enzyme expression (particularly CYP450 variants) can alter compound metabolism rates.
• Reproductive considerations — Many compounds have unknown or potentially harmful effects on fertility, pregnancy, and breastfeeding.

Hormonal Considerations

Menstrual Cycle Timing

Some compounds may be more effective or better tolerated at specific cycle phases:

• Follicular phase (Days 1–14): Estrogen is rising. Generally better tolerated period for introducing new compounds. Growth-related peptides may show enhanced response.
• Luteal phase (Days 15–28): Progesterone dominant. Some women report increased sensitivity to side effects. Consider reducing doses or timing injections earlier in the day.
• Ovulation window (Days 12–16): Hormonal peak. Avoid introducing new compounds during this sensitive window.

Hormonal Contraceptives

Women on hormonal birth control should be aware:

• Combined oral contraceptives may alter the metabolism of certain compounds through liver enzyme interactions.
• Hormonal IUDs (localized progestin) generally have fewer systemic interactions.
• Track any cycle irregularities when starting a new compound — this may indicate hormonal disruption.

Thyroid Interactions

Women are 5–8x more likely than men to have thyroid conditions. Compounds that affect metabolism (e.g., certain growth hormone secretagogues) should be used cautiously if you have a thyroid condition. Monitor TSH, Free T3, and Free T4 regularly.

Pregnancy & Breastfeeding Contraindications

Critical: The following applies to ALL research compounds discussed on this platform.

• Do NOT use any research compounds during pregnancy. Most peptides and research compounds have not been studied in pregnant women. The risk to fetal development is unknown.
• Do NOT use research compounds while breastfeeding. Peptides and small molecules can potentially transfer through breast milk.
• Discontinue all compounds at least 4–6 weeks before attempting conception to allow clearance.
• If you discover you are pregnant while on a protocol, discontinue immediately and consult your healthcare provider.

There are zero exceptions to this guidance on our platform. No research compound has sufficient safety data to justify use during pregnancy or lactation.

Dosing Adjustments for Women

As a general starting principle, women should begin at 50–75% of the standard male dose and titrate up based on response and tolerance.

General Dosing Framework

Key principle: Start low, go slow. Increase dose only after 1–2 weeks with no adverse effects.

Recommended Compounds for Women

Skin & Anti-Aging

• GHK-Cu — Copper peptide with strong evidence for skin regeneration, collagen synthesis, and wound healing. Topical and SubQ. Well-tolerated by women with minimal hormonal interaction.
• Epithalon — Telomerase-activating peptide. Anti-aging research. No known gender-specific concerns.
• BPC-157 — Systemic healing peptide. Supports gut health, joint repair, and tissue regeneration.

Hair Health

• GHK-Cu — Also studied for hair follicle stimulation and prevention of hair thinning.
• Thymosin Beta-4 (TB-500) — May support hair growth through wound healing and cellular migration pathways.
• PTD-DBM — Emerging research on hair follicle neogenesis (very early stage).

Body Composition

• Semaglutide / Tirzepatide — GLP-1 agonists for appetite regulation and fat loss. Follow standard titration protocols but start at the lowest available dose.
• CJC-1295 / Ipamorelin — Growth hormone secretagogue stack. Women may see good results at lower doses (100–150 mcg each).
• Tesamorelin — FDA-approved for lipodystrophy; strong fat reduction data. Use standard dosing.

Cognitive & Mood

• Selank — Anxiolytic peptide. Well-suited for women experiencing cycle-related anxiety. Intranasal, minimal side effects.
• Semax — Nootropic peptide for focus and cognitive performance. No known gender-specific concerns.
• Dihexa — Cognitive enhancement. Oral dosing at 10–20 mg. Use with caution; limited long-term data.

Recovery & Healing

• BPC-157 — Versatile healing peptide. Gut, joint, and tissue repair.
• TB-500 — Systemic recovery. Commonly stacked with BPC-157.
• KPV — Anti-inflammatory tripeptide. Promising for gut and skin inflammation.

Skin & Hair Protocols

Basic Skin Protocol (8 weeks)

• GHK-Cu: 1–2 mg SubQ daily (or topical 1% cream 2x daily)
• BPC-157: 250 mcg SubQ daily
• Support: Vitamin C (1000 mg), collagen peptides (10 g), adequate hydration

Hair Support Protocol (12 weeks)

• GHK-Cu: 1 mg SubQ daily
• TB-500: 500 mcg SubQ 2x/week (loading: 750 mcg for first 4 weeks)
• Support: Biotin (5000 mcg), iron (if deficient), zinc (15 mg)

Body Composition Protocol (12 weeks)

• CJC-1295 / Ipamorelin: 100 mcg each, SubQ before bed, 5 days on / 2 days off
• Semaglutide: Start at 0.25 mg/week, titrate to 0.5 mg after 4 weeks
• Support: Protein intake ≥ 1.2 g/kg, resistance training 3x/week minimum

Bloodwork Monitoring for Women

In addition to standard panels, women should specifically track:

Use our Bloodwork Tracker to log and trend your results over time.

Safety Checklist for Women

Before starting any protocol:

• ☐ Confirm you are not pregnant or breastfeeding
• ☐ Get baseline bloodwork (hormonal panel + standard CBC/CMP)
• ☐ Start at 50–75% of the standard dose
• ☐ Use only one new compound at a time (for isolation testing)
• ☐ Track your menstrual cycle for irregularities
• ☐ Schedule follow-up bloodwork at 4 and 8 weeks
• ☐ Have a plan to discontinue if side effects appear
• ☐ Store compounds properly (refrigerated after reconstitution)
• ☐ Use our Reconstitution Calculator for accurate dosing
• ☐ Report any adverse effects to your healthcare provider

Community Resources

• Join our Discord — we have a dedicated women's channel
• Browse r/BodyHackGuide for community discussions
• Use the Protocol Tracker to build and export your protocol
• Read our Beginner's Guide if you're new to research compounds

*This guide is reviewed and updated quarterly. Last reviewed: March 2026.*

*Have corrections or additions? Email corrections@bodyhackguide.co or post in our Discord #site-feedback channel.*

Related Guides